Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT04911907 · COMPLETED
Trial details
- NCT number
- NCT04911907
- Sponsor
- Beijing Biostar Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-22
- Primary completion
- 2025-05-31
- Enrollment
- 126
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.